The clinical information you need, at your fingertips.

Medical News for You

epocrates

1d

Test created by integration tests

Hadlima (adalimumab) - indicated for 1) moderate to severe rheumatoid arthritis in adult patients, 2) psoriatic arthritis in adult patients, 3) ankylosing spondylitis in adult patients, 4) moderate to severe Crohn disease in adult and pediatric patients 6 years and older, 5) various other indications.

epocrates

1mo

Test created by integration tests

Hadlima (adalimumab) - indicated for 1) moderate to severe rheumatoid arthritis in adult patients, 2) psoriatic arthritis in adult patients, 3) ankylosing spondylitis in adult patients, 4) moderate to severe Crohn disease in adult and pediatric patients 6 years and older, 5) various other indications.

epocrates

1mo

Test created by integration tests

Hadlima (adalimumab) - indicated for 1) moderate to severe rheumatoid arthritis in adult patients, 2) psoriatic arthritis in adult patients, 3) ankylosing spondylitis in adult patients, 4) moderate to severe Crohn disease in adult and pediatric patients 6 years and older, 5) various other indications.

epocrates

2mo

Test created by integration tests

Hadlima (adalimumab) - indicated for 1) moderate to severe rheumatoid arthritis in adult patients, 2) psoriatic arthritis in adult patients, 3) ankylosing spondylitis in adult patients, 4) moderate to severe Crohn disease in adult and pediatric patients 6 years and older, 5) various other indications.

epocrates

2mo

Test created by integration tests

Hadlima (adalimumab) - indicated for 1) moderate to severe rheumatoid arthritis in adult patients, 2) psoriatic arthritis in adult patients, 3) ankylosing spondylitis in adult patients, 4) moderate to severe Crohn disease in adult and pediatric patients 6 years and older, 5) various other indications.

epocrates

2mo

Test created by integration tests

Hadlima (adalimumab) - indicated for 1) moderate to severe rheumatoid arthritis in adult patients, 2) psoriatic arthritis in adult patients, 3) ankylosing spondylitis in adult patients, 4) moderate to severe Crohn disease in adult and pediatric patients 6 years and older, 5) various other indications.

epocrates

2mo

Test created by integration tests

Hadlima (adalimumab) - indicated for 1) moderate to severe rheumatoid arthritis in adult patients, 2) psoriatic arthritis in adult patients, 3) ankylosing spondylitis in adult patients, 4) moderate to severe Crohn disease in adult and pediatric patients 6 years and older, 5) various other indications.

epocrates

2mo

Test created by integration tests

Hadlima (adalimumab) - indicated for 1) moderate to severe rheumatoid arthritis in adult patients, 2) psoriatic arthritis in adult patients, 3) ankylosing spondylitis in adult patients, 4) moderate to severe Crohn disease in adult and pediatric patients 6 years and older, 5) various other indications.

test TCD testing chronological

2mo

test TCD testing chronological

test

test TCD testing chronological edited

2mo

test TCD (2)

test